newest glp-1 medications for type 2 diabetes 2025 New Guidelines in GLP-1 Pipeline Update: November 2025

For procurement teams evaluating peptide API suppliers, the combination of proven clinical efficacy, regulatory compliance, and manufacturing expertise represents a compelling value proposition that supports long-term business success

doi: 10.3390/biomedicines10102473 109 PincemailJMezianeS

FDA Approves Novo Nordisks New Wegovy HD Injection, Delivering the Highest Weight Loss to Date for a Wegovy Injection, Adding to Its Already Expansive Clinical Profile

109 Overall, there is a close association between TMAO and renal function, CKD, and cardiovascular outcomes in patients with CKD

With the rise of GIP/GLP-1 agonists such as tirzepatide (Mounjaro, Zepbound) and GLP-1 agonists like semaglutide (Ozempic, Wegovy) for type 2 diabetes and obesity, many women wonder if they need to change their birth control method